Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats

Toxicology

Volumn 232, Issue 3, 2007, Pages 200-215

  Sawant, Sharmilee P ^a   Dnyanmote, Ankur V ^a   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

CCl4; Liver injury; Phospho retinoblatoma; Thioacetamide; Tissue repair; Type 2 diabetes

Indexed keywords

CARBON TETRACHLORIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P21; RETINOBLASTOMA PROTEIN; STREPTOZOCIN; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TISSUE REPAIR;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARBON TETRACHLORIDE POISONING; CELL CYCLE; CYCLIN D1; CYCLIN-DEPENDENT KINASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOBLOTTING; INTERLEUKIN-6; LIVER DISEASES; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 33947423990     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.01.004     Document Type: Article

References (53)

1. 1. Genes Dev. 7 (1993) 812-821
2. 1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10 (1995) 1895-1904
3. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46 (1995) 223-234
4. Calabrese E.J., and Mehendale H.M. A review of the role of tissue repair as an adaptive strategy: why low doses are often non-toxic and why high doses can be fatal. Food Chem. Toxicol. 34 (1996) 301-311
5. Dajani O.F., Refsnes M., Guren T.K., Horn R.S., Thoresen G.H., and Christoffersen T. Elevated glucose concentrations inhibit DNA synthesis and expression of c-myc in cultured hepatocytes. Biochem. Biophys. Res. Commun. 202 (1994) 1476-1482
6. Dalu A., Rao P.S., and Mehendale H.M. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality. Environ. Health Perspect. 106 (1998) 597-606
7. Deane N.G., Parker M.A., Aramandla R., Diehl L., Lee W.J., Washington M.K., Nanney L.B., Shyr Y., and Beauchamp R.D. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 61 (2001) 5389-5395
8. 1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats. Toxicol. Appl. Pharmacol. 207 (2005) 89-102
9. Devi S.S., and Mehendale H.M. NF-kB signaling in impaired liver tissue repair in thioacetamide-treated type 1 diabetic rats. Eur. J. Pharmacol. 523 (2005) 127-136
10. Devi S.S., Philip B.K., Warbritton A., Latendresse J.R., and Mehendale H.M. Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide. Toxicology 226 (2006) 107-116
11. Donthamsetty S., Bhave V.S., Mitra M., Latendresse J.R., and Mehendale H.M. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 45 (2007) 391-403
12. Duzgun S.A., Rasque H., Kito H., Azuma N., Li W., Basson M.D., Gahtan V., Dudrick S.J., and Sumpio B.E. Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J. Cell Biochem. 76 (2000) 567-571
13. El-Serag H.B., and Everhart J.E. Diabetes increases the risk of acute hepatic failure. Gastroenterology 122 (2002) 1822-1828
14. El-Serag H.B., Tran T., and Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004) 460-468
15. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
16. Hanasono G.K., Cote M.G., and Plaa G.L. Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto-zotocin-diabetic rats. J. Pharmacol. Exp. Ther. 192 (1975) 592-604
17. Hanasono G.K., Witschi H., and Plaa G.L. Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc. Soc. Exp. Biol. Med. 149 (1975) 903-907
18. James L.P., Lamps L.W., McCullough S., and Hinson J.A. Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem. Biophys. Res. Commun. 309 (2003) 857-863
19. 4 hepatotoxicity. Biochem. Pharmacol. 40 (1990) 859-866
20. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., and Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31 (2000) 149-159
21. Kulkarni S.G., Warbritton A., Bucci T.J., and Mehendale H.M. Antimitotic intervention with colchicine alters the outcome of o-DCB-induced hepatotoxicity in Fischer 344 rats. Toxicology 120 (1997) 79-88
22. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
23. Leclercq I.A., Field J., and Farrell G.C. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124 (2003) 1451-1464
24. Ledda-Columbano G.M., Coni P., Curto M., Giacomini L., Faa G., Oliverio S., Piacentini M., and Columbano A. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am. J. Pathol. 139 (1991) 1099-1109
25. Lorenzi M., Cagliero E., and Toledo S. Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34 (1985) 621-627
26. Mak D.H., and Ko K.M. Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant/detoxification system in streptozotocin-induced short-term diabetic rats: effects of insulin and Schisandrin B treatment. Mol. Cell Biochem. 175 (1997) 225-232
27. Mangipudy R.S., Chanda S., and Mehendale H.M. Hepatocellular regeneration: key to thioacetamide autoprotection. Pharmacol. Toxicol. 77 (1995) 182-188
28. Mangipudy R.S., Chanda S., and Mehendale H.M. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ. Health Perspect. 103 (1995) 260-267
29. Mangipudy R.S., Rao P.S., and Mehendale H.M. Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity. Environ. Health Perspect. 104 (1996) 744-749
30. McGinn S., Saad S., Poronnik P., and Pollock C.A. High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E708-E717
31. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33 (2005) 41-51
32. Mehendale H.M., Thakore K.N., and Rao C.V. Autoprotection: stimulated tissue repair permits recovery from injury. J. Biochem. Toxicol. 9 (1994) 131-139
33. Pascal M.M., Forrester J.V., and Knott R.M. Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells. Curr. Eye Res. 19 (1999) 162-170
34. Pestell R.G., Albanese C., Reutens A.T., Segall J.E., Lee R.J., and Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20 (1999) 501-534
35. Rao P.S., Lyn-Cook B.D., Littlefield N.A., and Mehendale H.M. High glucose alters cell proliferation dynamics in human hepatoma cells. Int. J. Toxicol. 18 (1999) 297-306
36. Rojas S., Rojas R., Lamperti L., Casanello P., and Sobrevia L. Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Exp. Physiol. 88 (2003) 209-219
37. Sawant S.P., Dnyanmote A.V., Shankar K., Limaye P.B., Latendresse J.R., and Mehendale H.M. Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J. Pharmacol. Exp. Ther. 308 (2004) 694-704
38. Sawant S.P., Dnyanmote A.V., Warbritton A., Latendresse J.R., and Mehendale H.M. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol. 211 (2006) 221-232
39. Shankar K., Vaidya V.S., Corton J.C., Bucci T.J., Liu J., Waalkes M.P., and Mehendale H.M. Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. FASEB J. 17 (2003) 1748-1750
40. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
41. 4 hepatotoxicity and lethality. J. Hepatol. 20 (1994) 267-274
42. Soni M.G., and Mehendale H.M. Role of tissue repair in toxicologic interactions among hepatotoxic organics. Environ. Health Perspect. 106 Suppl. 6 (1998) 1307-1317
43. Swamy-Mruthinti S., Shaw S.M., Zhao H.R., Green K., and Abraham E.C. Evidence of a glycemic threshold for the development of cataracts in diabetic rats. Curr. Eye Res. 18 (1999) 423-429
44. Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J. Clin. Invest. 112 (2003) 978-980
45. Terada Y., Nakashima O., Inoshita S., Kuwahara M., Sasaki S., and Marumo F. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int. 56 (1999) 1378-1390
46. Torbenson M., Yang S.Q., Liu H.Z., Huang J., Gage W., and Diehl A.M. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am. J. Pathol. 161 (2002) 155-161
47. Tsiani E., Lekas P., Fantus I.G., Dlugosz J., and Whiteside C. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E161-E169
48. Wang T., Fontenot R.D., Soni M.G., Bucci T.J., and Mehendale H.M. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol. Appl. Pharmacol. 166 (2000) 92-100
49. Wang T., Shankar K., Bucci T.J., Warbritton A., and Mehendale H.M. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol. Appl. Pharmacol. 173 (2001) 27-37
50. Wang, T., Shankar, K., Ronis, M.J., Mehendale, H.M., 2007. Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit. Rev. Toxicol., 37, in press.
51. Wang T., Shankar K., Ronis M.J., and Mehendale H.M. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J. Pharmacol. Exp. Ther. 294 (2000) 473-479
52. Watkins III J.B., Sanders R.A., and Beck L.V. The effect of long-term streptozotocin-induced diabetes on the hepatotoxicity of bromobenzene and carbon tetrachloride and hepatic biotransformation in rats. Toxicol. Appl. Pharmacol. 93 (1988) 329-338
53. Wenner C.E., and Yan S. Biphasic role of TGF-beta1 in signal transduction and crosstalk. J. Cell Physiol. 196 (2003) 42-50